title: Disclosing clinical trial results: publicity, significance and independence.
authors.affiliation: Program on the Ethics of the New Biosciences, James Martin 21st Century School/Faculty of Philosophy, University of Oxford, 16/17 St. Ebbes Street, Oxford, United Kingdom. matthew.liao@philosophy.ox.ac.uk
authors.forename: S Matthew
authors.initials: SM
authors.lastname: Liao
authors.forename: Mark
authors.initials: M
authors.lastname: Sheehan
authors.forename: Steve
authors.initials: S
authors.lastname: Clarke
mesh_terms: D002986:Clinical Trials as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence; D003132:Commerce; D003219:Confidentiality / Q000941:ethics / Q000331:legislation & jurisprudence; D016265:Conflict of Interest / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000941:ethics* / Q000331:legislation & jurisprudence; D026689:Ethical Analysis; D028744:Ethics Committees, Research; D006801:Humans; D007258:Informed Consent / Q000941:ethics*; D016365:Liability, Legal; D028681:Moral Obligations; D012108:Research Personnel; D035842:Research Subjects; D035844:Researcher-Subject Relations / Q000941:ethics*; D012945:Social Values; D016896:Treatment Outcome; D014342:Truth Disclosure / Q000941:ethics*; D014481:United States; D014486:United States Food and Drug Administration